Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
bristol-myers squibb
clinical trials
intercept pharmaceuticals
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
nonalcoholic steatohepatitis
obeticholic acid
2
×
san diego blog main
2
×
san diego top stories
san francisco blog main
san francisco top stories
4d molecular therapeutics
abbvie
acne
agenus
allergan
astrazeneca
auris health
avexis
bayer
biomx
biotech
bladder cancer
boulder/denver blog main
boulder/denver top stories
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
celgene
centers for medicare and medicaid services
clinical data
deals
detroit blog main
What
approved
disease
2
×
drug
fatty
known
liver
nash
bio
companies
data
digital
epidemic
fda
frenzied
growing
horizon
intercept
led
marketed
medicine
merck
new
news
nonalcoholic
race
roundup
steatohepatitis
strikes
tokens
track
treatment
Language
Current search:
disease
×
" san diego blog main "
×
" obeticholic acid "
×
" new york top stories "
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug